Immune checkpoint inhibitors and BRAK/MEK inhibitors for treating advanced malignant melanoma

Agency for Care Effectiveness (ACE)
Record ID 32018002581
Project Status: Completed
Year Published: 2022
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Singapore
MeSH Terms
  • Melanoma
  • Immune Checkpoint Inhibitors
  • Nivolumab
  • Antineoplastic Combined Chemotherapy Protocols
  • Protein Kinase Inhibitors
  • Antineoplastic Agents, Immunological
Organisation Name: Agency for Care Effectiveness (ACE)
Contact Address: Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
Contact Email:
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.